| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 07/02/2008 | CN100398554C Linker compound, ligand, and producing method thereof |
| 07/01/2008 | US7393922 Insecticidal Cry4Ba proteins with enhanced toxicity |
| 07/01/2008 | US7393920 Deprotecting amino acid linked to solid phase resin by admixing with solution in transparent vessel while irradiating with microwaves, coupling/activating/hybridizing amino acids, then cleaving |
| 07/01/2008 | US7393849 N-[4-Amidinobenzoyl]-N-[3-phenoxybenzyl]-3-(4-biphenyl)-alanyl-glycyl-amide; anticarcinogenic, antidiabetic, anticholesterol agent, cardiovascular disorders, osteoporosis |
| 07/01/2008 | US7393682 Polynucleotides encoding promyostatin polypeptides |
| 06/26/2008 | WO2008076904A1 Bis-sulfhydryl macrocyclization systems |
| 06/26/2008 | WO2008074128A1 Pharmaceutically acceptable salts of thymodepressin and processes for their manufacture |
| 06/26/2008 | WO2008048121A3 Macrocyclic cysteine protease inhibitors and compositions thereof |
| 06/26/2008 | US20080153759 Treatment methods using polypeptides related to amyloid precursor protein |
| 06/26/2008 | US20080153112 identification of a predominant ligand of CD8+ T cells that are responsible eq for type 1 diabetes. That ligand is islet-specific glucose-6-phosphatase catalytic subunit-related protein (IGRP). Several CD8+ T cell-binding peptides from IGRP are identified, including the peptide comprising amino acids |
| 06/26/2008 | US20080152703 Epitopes formed by non-covalent association of conjugates |
| 06/26/2008 | US20080152622 Quinoxalinyl macrocyclic hepatitis c serine protease inhibitors |
| 06/26/2008 | CA2686827A1 Bis-sulfhydryl macrocyclization systems |
| 06/26/2008 | CA2673421A1 Pharmaceutically acceptable salts of thymodepressin and processes for their manufacture |
| 06/25/2008 | EP1934243A1 Ring-closing metathesis process for the preparation of macrocyclic peptides |
| 06/25/2008 | EP1933864A2 Antibodies as t cell receptor mimics, methods of production and uses thereof |
| 06/25/2008 | EP1933642A1 Salt enhancing compounds and use |
| 06/25/2008 | EP1485345B1 Urokinase inhibitors, production and use thereof |
| 06/25/2008 | EP1458393B1 Substituted diketopiperazines as oxytocin antagonists |
| 06/24/2008 | US7390910 Antitumor, anticancer agents; for drug resistant tumors, cancers |
| 06/24/2008 | US7390896 Preventing the deposits of amyloid protein, treating neurodegenerative disease, Alzheimer's disease and Down's Syndrome; {[carbamoyl]cycloalkyl}-N-(2-oxo-5-phenyl((S)-3H-benzo[f]1,4-diazepin-3-yl))- or (2-oxo-5-phenyl((S)-3H-benzo[f]1,4-diazepin-3-yl))-carboxamide |
| 06/24/2008 | US7390784 Binary complexes formed have an enlarged target binding surface area and thus exhibit increased affinity, specificity or selectivity as compared to free drug forms |
| 06/24/2008 | US7390781 Methods of using truncated glial cell line-derived neurotrophic factor |
| 06/19/2008 | WO2008071738A1 Selective inhibitors of neurotensin degrading enzymes |
| 06/19/2008 | WO2008071081A1 Preparation of low bleeding anticoagulant fusion protein and its use |
| 06/19/2008 | WO2008071009A1 Novel ligand guided block copolymers for targeted drug delivery |
| 06/19/2008 | WO2008050133A3 Inhibition of beta-amyloid aggregation |
| 06/19/2008 | US20080146808 Antiapoptosis; cancers; inhibiting the caspases; |
| 06/19/2008 | US20080146642 Propanesulfonic acid amino acid prodrugs that can deliver 3-amino-1-propanesulfonic acid (3APS) by minimizing metabolism associated with that drug, particularly compounds that block or protect amino group of 3APS such that it avoids metabolism by transaminases or monoamine oxidase; Alzheimer's disease |
| 06/19/2008 | US20080146632 Fc Receptor Modulating Compounds and Compositions |
| 06/19/2008 | US20080146510 For suppressing cell proliferation/tumor growth or modulating immune system by transformation of T-lymphocytes or enhancement of natural killer cells |
| 06/19/2008 | CA2670054A1 Selective inhibitors of neurotensin degrading enzymes |
| 06/19/2008 | CA2571645A1 Pharmaceutically acceptable salts of thymodepressin and processes for their manufacture |
| 06/18/2008 | EP1931656A1 Novel drugs for dementia |
| 06/18/2008 | EP1537230A4 Fluorescent enzyme assay methods and compositions |
| 06/18/2008 | CN101200493A (3S)-N-(L-aminoacyl)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid, preparation method and uses thereof |
| 06/18/2008 | CN101199512A Hif hydroxylase inhibitors |
| 06/18/2008 | CN101199503A Hif hydroxylase inhibitors |
| 06/18/2008 | CN101199502A Hif hydroxylase inhibitors |
| 06/18/2008 | CN101199501A HIF hydroxylase inhibitors |
| 06/18/2008 | CN100395264C Method for synthesis of perindopril and its pharmaceutically acceptable salts |
| 06/17/2008 | US7388098 Dynamic resolution of isomers and resolved isomers |
| 06/17/2008 | US7388017 Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease |
| 06/17/2008 | US7387778 Therapeutic methods and compositions for the treatment of impaired interpersonal and behavioral disorders |
| 06/17/2008 | CA2331961C Sweetener composition |
| 06/17/2008 | CA2331768C Sweetener composition |
| 06/17/2008 | CA2186497C Factor xa inhibitors |
| 06/12/2008 | WO2008070347A2 Betulin-peptide conjugates |
| 06/12/2008 | WO2008033389A3 Macrocyclic hcv inhibitors and their uses |
| 06/12/2008 | WO2008008348A3 Method and compositions for treating stroke with fever |
| 06/12/2008 | US20080139785 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis |
| 06/12/2008 | US20080139670 Drug Delivery System |
| 06/12/2008 | US20080139461 Containing the sequence RGD for the preparation of appropriately functionalised antagonists of alpha v beta 3 and alpha v beta 5 integrins; treatment of altered angiogenic phenomena or for the preparation of diagnostically useful compounds |
| 06/12/2008 | US20080139456 Macrocyclic Sh2 Domain Binding Inhibitors |
| 06/12/2008 | US20080138278 Conjugates of rgd peptides and porphyrin or (bacterio) chlorohyll photosynthesizers and their uses |
| 06/12/2008 | CA2671410A1 Peptide and treatment for hiv-1 infection |
| 06/11/2008 | EP1930021A2 Novel amide derivatives as growth hormone secretagogues |
| 06/11/2008 | EP1443816B1 Methods of treating disorders related to apoe |
| 06/11/2008 | CN100393742C Antibacterial tripeptides and modified chemicals, and application |
| 06/11/2008 | CN100393356C Modified cytokines for use in cancer therapy |
| 06/10/2008 | US7385035 Cytotoxic protein and utilization thereof |
| 06/10/2008 | US7385029 crystallizing amorphous N2-(N,N-dimethyl-L-valyl)-N-[(1 S,2R)-2-methoxy-4-[(2S)-2-[(1R,2R)-1-methoxy-2-methyl-3-oxo-3-[(2-phenylethyl)amino]propyl]-1-pyrrolidinyl]-1-[(S)-1-methylpropyl]-4-oxobutyl]-N-methyl-L-valinamide (TZT-1027) or salts from diethyl ether or ethyl acetate or mixed solvent; stability |
| 06/10/2008 | US7384933 Derivatives of 2-hydroxytetrahydrofuran and their use as medicaments |
| 06/10/2008 | US7384758 Bioluminescent protease assay with modified aminoluciferin or derivatives thereof |
| 06/10/2008 | US7384636 Which induce an antibody specific to cell surface protein antigen from Streptococcus; use in vaccine production and preventing dental caries |
| 06/10/2008 | CA2250075C Methods for diagnosing and treating alzheimer's disease |
| 06/10/2008 | CA2227607C Penicillaminamide derivatives |
| 06/10/2008 | CA2129046C Opioid diarylmethylpiperazines and piperidines |
| 06/05/2008 | WO2008067270A1 Macrocyclic grb2 sh2 domain-binding inhibitors |
| 06/05/2008 | WO2008066070A1 Dipeptidyl peptidase-iv inhibitor |
| 06/05/2008 | WO2008064465A1 Crystalline d-isoglutamyl-d-tryptophan and the mono ammonium salt of d-isoglutamyl- d-tryptophan |
| 06/05/2008 | US20080132678 Such as N-(4-morpholine)carbonyl-(O-benzyl)-L-tyrosine-L-leucine boronic acid for reducing rate of degradation of proteins; proteasome inhibitors |
| 06/05/2008 | US20080132469 Sh2 domain binding inhibitors |
| 06/05/2008 | US20080132454 bioavailable ACE-inhibiting peptides that are absorbed intact; protein hydrolysate; hydrolyzing the casein fraction using a protease, subtilisin; foods, beverages |
| 06/05/2008 | US20080131430 Therapeutic Administration Of The Scrambled Anti-Angiogenic Peptide C16Y |
| 06/05/2008 | US20080131368 Technetium-base radiopharmaceuticals; biocompatability; kits |
| 06/05/2008 | CA2672369A1 Crystalline d-isoglutamyl-d-tryptophan and the mono ammonium salt of d-isoglutamyl-d-tryptophan |
| 06/04/2008 | EP1926743A1 2-(AMINOMETHYL)-5-CHLOROBENZYLAMIDE DERIVATIVES AND THEIR USE AS INHIBITORS OF THE CLOTTING FACTOR Xa |
| 06/04/2008 | CN101193909A Compound having photosensitization activity, photoelectrode, and photosensitization-type solar cell |
| 06/04/2008 | CN101193908A Organic compounds |
| 06/04/2008 | CN101190941A Polypeptide with thrombus dissolving activity and its preparation method and application |
| 06/04/2008 | CN101190939A Oligopeptide-copper complex with blood vessel extending and thrombus dissolving activity and its preparation method and application |
| 06/04/2008 | CN100391967C Hepatitis C tripeptide inhibitors |
| 06/03/2008 | US7381707 Administering a tetrapeptide or derivative containing (from left to right)units of 1) valene, leucine, isoleucine or cyclohexylalanine, 2) valine, leucine, isoleucine or cyclohexylalanine, 3) glycine or alanine, and 4) lysine, arginine or homoarginine; topical, intraocular implantation or injection |
| 06/03/2008 | US7381699 Reagents and methods for smooth muscle therapies |
| 06/03/2008 | US7381534 Immunoglobulin binding immunogenic polypeptide of given sequence; test kits for allergy detection |
| 06/03/2008 | CA2180829C Cephalosporin synthesis |
| 05/29/2008 | WO2008064066A1 Hepatitis c virus inhibitors |
| 05/29/2008 | WO2008062911A1 Reagent for introduction of protein or gene |
| 05/29/2008 | WO2008062232A1 Depsipeptides and their therapeutic use |
| 05/29/2008 | WO2008062201A1 Depsipeptides and their therapeutic use |
| 05/29/2008 | WO2007074456A3 Inhibition of cxcr4 and/or cell motility by phenylalanine, cysteine or peptides containing said aminoacids |
| 05/29/2008 | WO2007005300A3 Treatment of dry eye |
| 05/29/2008 | US20080125376 Viricide against hepatitis virus; pyrrole derivatives as, for example, 3-acetyl-4,5-dimethyl-2-pyrrole carboxylic acid |
| 05/29/2008 | US20080125372 Biologically Active Peptide Vapeehptllteaplnpk Derivatives |
| 05/29/2008 | US20080125355 Endogenous Peptide and Active Subfragments Thereof |
| 05/29/2008 | US20080124449 mung bean protein degradation product obtained by hydrolyzing a mung bean-derived protein with a protease contained in anti-hypertensive, anti-arteriosclerotic, and antiobesity agent; side-effects reduction |
| 05/29/2008 | CA2670372A1 Depsipeptides and their therapeutic use |
| 05/29/2008 | CA2670223A1 Depsipeptides and their therapeutic use |
| 05/29/2008 | CA2669856A1 Hepatitis c virus inhibitors |